ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 186 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $17,987,000 | +56.2% | 1,667,000 | 0.0% | 0.73% | +63.5% |
| Q3 2015 | $11,519,000 | -58.4% | 1,667,000 | -40.7% | 0.45% | -50.3% |
| Q1 2015 | $27,708,000 | -22.5% | 2,810,164 | -3.8% | 0.90% | -30.2% |
| Q4 2014 | $35,774,000 | +37556.8% | 2,920,300 | +23262.4% | 1.28% | +32025.0% |
| Q2 2014 | $95,000 | -68.9% | 12,500 | -86.5% | 0.00% | -66.7% |
| Q1 2014 | $305,000 | -97.7% | 92,804 | -94.3% | 0.01% | -98.1% |
| Q2 2013 | $13,332,000 | – | 1,629,833 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |